Analyzing...
In continuation of our letter dated 30th April, 2024 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the Conference Call held on 13th May, 2024, on the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2024, is available on the Company’s website at https://www.piramalpharma.com/financial-reports Kindly take the above on record.
Thanking you,